[Hemodialysis-associated hypertension; pathophysiology and therapy].
Suzuki
Hiromichi
H
Department of Nephrology, Saitama Medical School.
D000804:Angiotensin II / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004921:Erythropoietin / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000150:complications*; D012079:Renal Circulation; D006435:Renal Dialysis / Q000009:adverse effects*; D012084:Renin-Angiotensin System / Q000502:physiology; D012891:Sleep Apnea Syndromes / Q000150:complications; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014655:Vascular Resistance / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004921:Erythropoietin; D000804:Angiotensin II